5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.93▲ | 0.91▲ | 0.91▲ | 0.92▲ | 0.97▼ |
MA10 | 0.92▲ | 0.90▲ | 0.91▲ | 0.98▼ | 2.07▼ |
MA20 | 0.90▲ | 0.90▲ | 0.92▲ | 1.00▼ | 3.21▼ |
MA50 | 0.91▲ | 0.92▲ | 0.96▼ | 2.95▼ | 5.28▼ |
MA100 | 0.92▲ | 1.00▼ | 0.98▼ | 3.57▼ | 9.27▼ |
MA200 | 0.99▼ | 1.01▼ | 1.37▼ | 5.08▼ | 77.66▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.005▲ | 0.006▲ | 0.118▲ | -0.234▼ |
RSI | 60.142▲ | 55.090▲ | 51.150▲ | 35.375▼ | 36.589▼ |
STOCH | 86.026▲ | 59.258 | 55.499 | 13.760▼ | 3.086▼ |
WILL %R | -11.830▲ | -11.830▲ | -11.830▲ | -86.084▼ | -98.323▼ |
CCI | 66.387 | 124.094▲ | 113.071▲ | -37.784 | -74.264 |
Wednesday, June 18, 2025 04:58 PM
NanoVibronix Regains Nasdaq Compliance. ELMSFORD, N.Y., April 11, 2025--NanoVibronix, Inc. (NASDAQ: NAOV) (the "Company" or "NanoVibronix"), a medical technology company specializing in non ...
|
Wednesday, June 11, 2025 05:01 AM
NanoVibronix, Inc. (NASDAQ: NAOV) is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings.
|
Wednesday, June 11, 2025 05:01 AM
TYLER, Texas--(BUSINESS WIRE)-- NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
24/06/25 | 0.9346 | 0.9346 | 0.922 | 0.9282 | 343,681 |
23/06/25 | 0.9055 | 0.92 | 0.8801 | 0.9051 | 306,014 |
20/06/25 | 0.9503 | 0.9545 | 0.90 | 0.92 | 337,754 |
18/06/25 | 0.91 | 0.98 | 0.91 | 0.9545 | 528,226 |
17/06/25 | 0.95 | 0.95 | 0.84 | 0.9001 | 747,269 |
16/06/25 | 0.9996 | 1.00 | 0.925 | 0.9802 | 1,192,256 |
13/06/25 | 1.04 | 1.115 | 1.01 | 1.02 | 1,228,458 |
12/06/25 | 1.08 | 1.15 | 1.02 | 1.15 | 3,068,994 |
11/06/25 | 1.07 | 1.66 | 1.01 | 1.20 | 99,517,546 |
10/06/25 | 0.841 | 0.8552 | 0.8099 | 0.811 | 602,256 |
|
|
||||
|
|
||||
|
|